🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the effect of ultrasound-guided thoracic paravertebral nerve...
Status
Completed
Location
The First hosptial of Qinhuangdao
Start Date
2022-05-12
Trial ID
NCT05364216
Hypertension is a major risk factor for cardiovascular morbidity and mortal...
Status
Terminated
Location
Marine Parade Polyclinic
Start Date
2017-12-20
Trial ID
NCT03368417
Treatments Being Tested
The current norm in clinical practice for the treatment of choroidal neovas...
Status
Completed
Location
Toronto Western Hospital
Start Date
2011-11
Trial ID
NCT01453920
Treatments Being Tested
Idiopathic inflammatory myopathies (IIM) are a group of autoimmune conditio...
Status
Recruiting
Location
Singapore General Hospital
Start Date
2024-12-26
Trial ID
NCT07775235
Treatments Being Tested
Rhinosinusitis is one of the most prevalent diseases within the United Stat...
Status
Unknown
Location
Department of Otolaryngology-Head and Neck Surgery at the University of Virginia Health System
Start Date
2015-02
Trial ID
NCT02413125
Treatments Being Tested
The tripod of OA clinical treatment is education, weight loss and exercise....
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04052308
The Omicron variant of concern (VOC) is currently rapidly spreading worldwi...
Status
Unknown
Location
Sheba Medical Center
Start Date
2021-12-27
Trial ID
NCT05231005
Treatments Being Tested
There is no study that has investigated the effects of medical nutrition th...
Status
Completed
Location
Goztepe Prof. Dr. Suleyman Yalcin City Hospital
Start Date
2023-10-14
Trial ID
NCT06813131
Treatments Being Tested
Nelfinavir will increase the efficacy of Cisplatin based chemo- radiation t...
Status
Completed
Location
University of Miami
Start Date
2012-01
Trial ID
NCT01485731
Purpose :Research into the impact of Qiliqiangxin capsule on IFN-γ，IL-4，NT-...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT02283450
Treatments Being Tested